Counterfeit Medicines

7/26/2019 Counterfeit Medicines

1/20

Introduction

The problem of DrugCounterfeiting is as old ascivilization.

17thcentury Cinchona bark wasbeing faked

Drug counterfeiting has

assumed such an alarming ratethat it is now being perceived tobe a Public ealth hazard thatmerits !lobal attention


2/20

Definition

"ccording to#lack$s Dictionarythe term %counterfeit drug$ refersto a drug made by someone

other than the genuinemanufacturer& by copying orimitating an original productwithout "uthority or 'ight& witha view to deceive or defraud andmarketing the product as theoriginal


3/20

(..). has come out with a

definition to guide national drug

regulatory authorities*

" C)+, -'-/ 0-D/C/,- /1

),- (/C /1 D-2/#-'" -23

",D '"+D+2-, 23

0/12"#-22-D with respect to

identity and or source


4/20

Contd.

Counterfeiting can apply to

both #'",D-D and !-,-'/C

products and these may

include products with

the C)''-C ingredients&

or with the ('),! active

ingredients

without "C /4- ingredients&

/,1+/C/-, "C /4- ingredients

"5- P"C5"!/,!.


5/20

W.H.O. Figures

ome figures presented by

(..). indicate the e6tent of

the problem:

1992-1994 survey uncovered 51 of

counterfeited drugs !it" no #ctive ingredient.

25 of $edicines in deve%o&ing countries

counterfeited or su'-st#nd#rdFD( re&orted 1 in 1) $edicines so%d

!or%d!ide !#s f#*e !it" no $edic#% effect.


6/20

Contd.

2++ c"i%dren died fro$ consu$&tion of

,#r#cet#$o% syru& cont#ining #nti-freee in

#ng%#des" /19920

25)) c"i%dren died #fter 'eing inocu%#ted

!it" counterfeited C..3. v#ccine /19950


7/20

Factors Encouraging

Counterfeiting of Drugs

Medicines are high value items for bothcurative and preventive health care.

Demand for medicine is innite.

Ingredients for producing counterfeit drugscheaper.

No infrastructure;No quality assurance;

High margins of cost.


8/20

1.

Lack of Political Will AndCommitment


9/20

2.

Lack of Appropriate DrugLegislation


10/20

3.

Absence of or Weak DrugRegulation


11/20

4.

! Weak Enforcement and PenalSanctions.


12/20

Illegal Trading in

pharmaceuticals: b !eof"o#er$!la%o&mith'line

Franchising

Parallel trading


13/20

Diversion or illegal tradingCounterfeiting

Counterfeiting


14/20

Corruption and conflict of interest

demand exceeding supply


15/20

high prices of medicines

inefficient co-operation betweenstakeholders


16/20

lack of regulation by exportingcountries and within free trade zones

Trade through several intermediaries


17/20

substitution

adulteration and re-use


18/20

/mpact on Public ealthre#t$ent f#i%ures

oss of confidence in "e#%t" c#re &roviders

W#ste of resources /'ot" tient 6govern$ent0

o! &roductivity


19/20

Conclusion

Cre#te &u'%ic #!#reness

7duc#te &u'%ic on detection

r#cing #nd tr#c*ing 'y #ut"orities /,O87 6 WH770

everer s#nctions for counterfeiters

3#nuf#cturers $ust 'e "e%d %i#'%e for t"ird rty inuriesresu%ting fro$ counterfeited drugs.


20/20

H(8 ;O

Counterfeit Medicines

Documents

Transcript of Counterfeit Medicines